[go: up one dir, main page]

PL2736488T3 - Kompozycje farmaceutyczne zawierające rifaksyminę, sposoby ich wytwarzania i ich zastosowanie do leczenia zakażeń pochwy - Google Patents

Kompozycje farmaceutyczne zawierające rifaksyminę, sposoby ich wytwarzania i ich zastosowanie do leczenia zakażeń pochwy

Info

Publication number
PL2736488T3
PL2736488T3 PL12761650T PL12761650T PL2736488T3 PL 2736488 T3 PL2736488 T3 PL 2736488T3 PL 12761650 T PL12761650 T PL 12761650T PL 12761650 T PL12761650 T PL 12761650T PL 2736488 T3 PL2736488 T3 PL 2736488T3
Authority
PL
Poland
Prior art keywords
rifaximin
processes
preparation
treatment
pharmaceutical compositions
Prior art date
Application number
PL12761650T
Other languages
English (en)
Inventor
Giuseppe Claudio Viscomi
Paola Maffei
Vittoria Lauro
Fiorella Calanni
Beatrice Vitali
Federica Cruciani
Original Assignee
Alfasigma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfasigma Spa filed Critical Alfasigma Spa
Publication of PL2736488T3 publication Critical patent/PL2736488T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PL12761650T 2011-07-29 2012-07-26 Kompozycje farmaceutyczne zawierające rifaksyminę, sposoby ich wytwarzania i ich zastosowanie do leczenia zakażeń pochwy PL2736488T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000461A ITBO20110461A1 (it) 2011-07-29 2011-07-29 Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
EP12761650.6A EP2736488B1 (en) 2011-07-29 2012-07-26 Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
PCT/IB2012/001438 WO2013017928A1 (en) 2011-07-29 2012-07-26 Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections

Publications (1)

Publication Number Publication Date
PL2736488T3 true PL2736488T3 (pl) 2015-12-31

Family

ID=44584299

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12761650T PL2736488T3 (pl) 2011-07-29 2012-07-26 Kompozycje farmaceutyczne zawierające rifaksyminę, sposoby ich wytwarzania i ich zastosowanie do leczenia zakażeń pochwy

Country Status (20)

Country Link
US (1) US10258610B2 (pl)
EP (1) EP2736488B1 (pl)
JP (1) JP5956575B2 (pl)
CN (1) CN103732212B (pl)
AU (1) AU2012291767B2 (pl)
CA (1) CA2841415C (pl)
DK (1) DK2736488T3 (pl)
EA (1) EA025047B1 (pl)
ES (1) ES2549560T3 (pl)
HR (1) HRP20151095T1 (pl)
HU (1) HUE026465T2 (pl)
IT (1) ITBO20110461A1 (pl)
MX (1) MX2014001139A (pl)
PL (1) PL2736488T3 (pl)
PT (1) PT2736488E (pl)
RS (1) RS54329B1 (pl)
SI (1) SI2736488T1 (pl)
TN (1) TN2014000009A1 (pl)
UA (1) UA111972C2 (pl)
WO (1) WO2013017928A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1698630T3 (pl) 2005-03-03 2014-12-31 Alfasigma Spa Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
US10543088B2 (en) * 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
EP2895111B1 (en) * 2012-09-14 2023-08-09 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US20160038468A1 (en) * 2013-03-15 2016-02-11 Alfa Wassermann S.P.A. Rifaximin for use in the treating of vaginal infections
PT3113774T (pt) 2014-03-06 2022-02-28 Elanco Animal Health Incorporated Composições de grapiprant e métodos de utilização das mesmas
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
RS60576B1 (sr) 2014-05-12 2020-08-31 Alfasigma Spa Priprema i upotreba tau kristalnog oblika rifaksimina solvatisanog sa degme
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US11224591B2 (en) * 2016-10-14 2022-01-18 Cipla Limited Pharmaceutical compositions comprising rifaximin
CN106860451A (zh) * 2017-02-28 2017-06-20 丹诺医药(苏州）有限公司 一种利福霉素‑硝基咪唑偶联分子的新应用
CN106902116B (zh) * 2017-02-28 2021-03-23 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮双靶标分子的应用
HUE062772T2 (hu) * 2019-04-05 2023-12-28 Gedea Biotech Ab Hüvelyi tabletta készítmény
EA202290122A1 (ru) * 2019-06-21 2022-03-17 Альфасигма С.П.А. Фармацевтические композиции в форме геля, содержащие ксилоглюкан и спирты, для регулируемого высвобождения активных ингредиентов

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1199374B (it) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
US5356625A (en) 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US5166959A (en) 1991-12-19 1992-11-24 Hewlett-Packard Company Picosecond event timer
IT1264494B1 (it) 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
EP2060183A3 (en) 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
IT1290679B1 (it) 1997-02-14 1998-12-10 Alfa Wassermann Spa Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
US20030059471A1 (en) 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US20030157174A1 (en) 2000-03-23 2003-08-21 Takayuki Tsukuda Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US20080262024A1 (en) 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US20050196418A1 (en) 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
PL1698630T3 (pl) 2005-03-03 2014-12-31 Alfasigma Spa Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
US20090186081A1 (en) 2006-01-05 2009-07-23 Lifecycle Pharma A/S Disintegrating Loadable Tablets
JP4887928B2 (ja) 2006-06-21 2012-02-29 株式会社デンソー 車両用通信システムの受信装置
AT503862B1 (de) * 2006-07-05 2010-11-15 Arc Austrian Res Centers Gmbh Pathogen-identifizierung anhand eines 16s oder 18s-rrna mikroarray
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
NZ575550A (en) 2006-09-22 2011-12-22 Cipla Ltd Rifaximin
ITMI20071241A1 (it) 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
ES2905795T3 (es) 2007-07-06 2022-04-12 Lupin Ltd Composiciones farmacéuticas de rifaximina
US8383151B2 (en) 2007-07-06 2013-02-26 Lupin Limited Pharmaceutical compositions of rifaximin
US8974825B2 (en) 2007-07-06 2015-03-10 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
WO2009084017A2 (en) * 2007-10-10 2009-07-09 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
JP5706693B2 (ja) 2008-02-25 2015-04-22 サリックス ファーマシューティカルズ リミテッド リファキシミンの型およびその使用
WO2010044093A1 (en) 2008-10-16 2010-04-22 Strides Arcolab Limited Formulations containing rifaximin
IT1397617B1 (it) 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
JO3635B1 (ar) * 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
ES2762442T3 (es) 2009-10-26 2020-05-25 Borody Thomas J Novedosa terapia de combinación entérica
BR112012012315A2 (pt) 2009-11-23 2018-10-16 Cipla Ltd composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou anus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de silicone e dispensador para composição farmacêutica
WO2011061519A2 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
CN101773465B (zh) 2010-01-19 2012-11-07 南京泛太化工医药研究所 以氨基酸为稳定剂的聚合物胶束载药系统
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2011110930A2 (en) 2010-03-10 2011-09-15 Lupin Limited Rifaximin ready-to-use suspension
US8513275B2 (en) 2010-06-03 2013-08-20 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
EP2582707A4 (en) 2010-06-16 2014-01-08 Apotex Pharmachem Inc POLYMORPHIC FORMS OF RIFAXIMINE
DK2593463T3 (da) 2010-07-12 2020-08-10 Salix Pharmaceuticals Inc Formuleringer af rifaximin og anvendelser deraf
JP2013537182A (ja) 2010-09-13 2013-09-30 シプラ・リミテッド 医薬組成物
IT1403847B1 (it) 2010-09-22 2013-11-08 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina e loro uso.
WO2012076832A1 (en) 2010-12-09 2012-06-14 Cipla Limited Suppositories comprising rifaximin
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.

Also Published As

Publication number Publication date
HUE026465T2 (en) 2016-05-30
US10258610B2 (en) 2019-04-16
HRP20151095T1 (hr) 2015-12-04
EP2736488A1 (en) 2014-06-04
AU2012291767B2 (en) 2016-10-06
SI2736488T1 (sl) 2015-12-31
US20130028971A1 (en) 2013-01-31
CN103732212B (zh) 2016-06-01
ITBO20110461A1 (it) 2013-01-30
EA201490264A1 (ru) 2014-08-29
MX2014001139A (es) 2014-02-27
DK2736488T3 (en) 2015-11-02
CN103732212A (zh) 2014-04-16
NZ620418A (en) 2015-03-27
WO2013017928A1 (en) 2013-02-07
JP2014521632A (ja) 2014-08-28
EP2736488B1 (en) 2015-09-09
EA025047B1 (ru) 2016-11-30
TN2014000009A1 (en) 2015-07-01
ES2549560T3 (es) 2015-10-29
JP5956575B2 (ja) 2016-07-27
RS54329B1 (sr) 2016-02-29
PT2736488E (pt) 2015-11-20
AU2012291767A1 (en) 2014-01-30
CA2841415C (en) 2016-03-22
CA2841415A1 (en) 2013-02-07
UA111972C2 (uk) 2016-07-11

Similar Documents

Publication Publication Date Title
SI2736488T1 (sl) Farmacevtski sestavki, ki obsegajo rifaksimin, postopki za njihovo pripravo in njihova uporaba v zdravljenju vaginalnih infekcij
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
PT2667849T (pt) Composição efervescente em forma sólida para utilização em aplicações vaginais para o tratamento de infeções vaginais
IL221940A (en) Small anti-infective compounds, pharmaceutical preparations containing them and their use in the preparation of drugs for the treatment of bacterial infections
SI2627334T1 (sl) Sestavki za uporabo pri zdravljenju virusnih infekcij
IL235923A0 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
IL219750A (en) Triazulophyridines, a method of preparing them, pharmaceutical preparations containing them and their use in the treatment or prevention of disease
IL221160A (en) 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation
ZA201307963B (en) 1,6- diazabicyclo [3,2,1] octan-7 one derivatives and their use in the treatment of bacterial infections
IL230874A (en) History of dihydroquinoline-2-on-egg scallops, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
IL232308A (en) Compounds as modulators of atp-linked casting, pharmaceuticals containing them and their use in the preparation of drugs for the treatment of diseases and processes for their preparation
ZA201209632B (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
EP2675469A4 (en) COMPOSITIONS, DEVICES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
IL232325A0 (en) 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease
IL235429A0 (en) (r)-nifortal, its use in the treatment of infections and the preparation of (r) and (s)-nifortal
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
PL2903608T3 (pl) Kompozycja farmaceutyczna obejmująca kwas propionowy do stosowania w leczeniu infekcji wirusowych
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
PL2678307T3 (pl) Zastosowanie pochodnych poliaminoizoprenylu w leczeniu antybiotykami lub środkami antyseptycznymi
ZA201308025B (en) The use of secnidazole in treating dental infections
IL226939A (en) Diarylpyridazinone derivatives, their preparation, and their use in the treatment of humans
ZA201404052B (en) 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in treatment of endometriosis
PT2797914E (pt) Sulfóxido de nifuratel para uso no tratamento de infeções bacterianas